Ireland Opioid Receptor Agonist Market (2025-2031) | Share, Forecast, Segmentation, Competitive Landscape, Analysis, Companies, Growth, Size & Revenue, Value, Industry, Trends, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Ireland Country Macro Economic Indicators

3.2 Ireland Opioid Receptor Agonist Market Revenues & Volume, 2021 & 2031F

3.3 Ireland Opioid Receptor Agonist Market - Industry Life Cycle

3.4 Ireland Opioid Receptor Agonist Market - Porter's Five Forces

3.5 Ireland Opioid Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F

3.6 Ireland Opioid Receptor Agonist Market Revenues & Volume Share, By Receptor Binding, 2021 & 2031F

3.7 Ireland Opioid Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.8 Ireland Opioid Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 Ireland Opioid Receptor Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.10 Ireland Opioid Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic pain conditions in Ireland

4.2.2 Growing awareness and acceptance of opioid therapy for pain management

4.2.3 Rise in geriatric population requiring pain relief medications

4.2.4 Technological advancements in opioid receptor agonist formulations

4.2.5 Government initiatives to improve access to pain management treatments

4.3 Market Restraints

4.3.1 Stringent regulations and guidelines for opioid prescribing and dispensing

4.3.2 Concerns over opioid abuse and addiction leading to stricter monitoring

4.3.3 Limited reimbursement policies for opioid medications

4.3.4 Growing preference for non-opioid alternatives for pain management

4.3.5 Negative perceptions and stigma associated with opioid use

6.1 Ireland Opioid Receptor Agonist Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Drugs, 2021- 2031F

6.1.3 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Fentanyl, 2021- 2031F

6.1.4 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Codeine, 2021- 2031F

6.1.5 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Morphine, 2021- 2031F

6.1.6 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Buprenorphine, 2021- 2031F

6.1.7 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F

6.2 Ireland Opioid Receptor Agonist Market, By Receptor Binding

6.2.1 Overview and Analysis

6.2.2 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Full Agonist, 2021- 2031F

6.2.3 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Partial Agonist, 2021- 2031F

6.3 Ireland Opioid Receptor Agonist Market, By Indication

6.3.1 Overview and Analysis

6.3.2 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Pain management, 2021- 2031F

6.3.3 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Cough Suppression, 2021- 2031F

6.3.4 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Diarrhoea suppression, 2021- 2031F

6.3.5 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F

6.4 Ireland Opioid Receptor Agonist Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Intravenous, 2021- 2031F

6.4.3 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.4.4 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F

6.5 Ireland Opioid Receptor Agonist Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Homecare, 2021- 2031F

6.5.4 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.5.5 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F

6.6 Ireland Opioid Receptor Agonist Market, By Distribution Channel

6.6.1 Overview and Analysis

6.6.2 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.6.3 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.6.4 Ireland Opioid Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7.1 Ireland Opioid Receptor Agonist Market Export to Major Countries

7.2 Ireland Opioid Receptor Agonist Market Imports from Major Countries

8.1 Number of prescriptions for opioid receptor agonists

8.2 Patient satisfaction with opioid therapy for pain management

8.3 Rate of opioid-related adverse events

8.4 Utilization of telemedicine for opioid therapy consultations

8.5 Adoption rate of abuse-deterrent opioid formulations

9.1 Ireland Opioid Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F

9.2 Ireland Opioid Receptor Agonist Market Opportunity Assessment, By Receptor Binding, 2021 & 2031F

9.3 Ireland Opioid Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F

9.4 Ireland Opioid Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 Ireland Opioid Receptor Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.6 Ireland Opioid Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Ireland Opioid Receptor Agonist Market Revenue Share, By Companies, 2024

10.2 Ireland Opioid Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters